Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HemOnc.org: A Collaborative Online Knowledge Platform for Oncology Professionals.

Jeremy L Warner1, Andrew J Cowan2, Aric C Hall2

  • 1Vanderbilt University, Nashville, TN; Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, WA; University of Wisconsin School of Medicine and Public Health, Madison, WI; Massachusetts General Hospital, Boston, MA Jeremy.warner@vanderbilt.edu.

Journal of Oncology Practice
|March 5, 2015
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
Same author

Announcing a New Article Type in <i>JCO Clinical Cancer Informatics</i>: The Resource Report.

JCO clinical cancer informatics·2026
Same author

Multi-Modal Deep Learning-Based Model to Predict Burkitt Lymphoma Recurrence.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Making LLM Predictions Interpretable: Fine-Tuning GPT-4o for Early Discontinuation of Cancer Medication.

Studies in health technology and informatics·2026
Same author

Leveraging AI to Evaluate Minimal Residual Disease Endpoint Surrogacy in Multiple Myeloma.

Cancer research communications·2026
This summary is machine-generated.

HemOnc.org is a collaborative wiki providing comprehensive chemotherapy drug and regimen information. This freely accessible online resource is widely used by healthcare professionals globally.

Area of Science:

  • Oncology
  • Pharmacology
  • Medical Informatics

Background:

  • Chemotherapy knowledge is vast and rapidly evolving.
  • A centralized, freely accessible repository for chemotherapy information is lacking.
  • This gap hinders efficient cancer care and research.

Purpose of the Study:

  • To establish HemOnc.org, a comprehensive, collaborative, and freely accessible online wiki for chemotherapy information.
  • To address the unmet need for a centralized repository of chemotherapy drug and regimen data.
  • To support hematology/oncology professionals with up-to-date, standardized information.

Main Methods:

  • Developed an online wiki using wiki software hosted on a cloud platform.
  • Included detailed information on chemotherapy drugs, regimens, and variants.

Related Experiment Videos

  • Implemented a fully referenced and standardized format for all content.
  • Allowed accredited users to contribute and update information.

    • Main Results:

    • HemOnc.org launched in November 2011 and has experienced rapid growth.
    • The wiki contains information on 383 drugs and 1,298 chemotherapy regimens across 92 disease subtypes.
    • The platform attracts over 2,000 weekly visitors from the US and internationally.
    • User evaluations confirm the site is useful, usable, and recommendable.

    Conclusions:

    • HemOnc.org is the largest free online source for chemotherapy drug and regimen information.
    • The resource is widely utilized by healthcare professionals.
    • Future enhancements will focus on metadata, efficacy, and toxicity data to further increase its value.